299 related articles for article (PubMed ID: 33581321)
1. A new horizon for the old antibacterial drug clofoctol.
Bailly C; Vergoten G
Drug Discov Today; 2021 May; 26(5):1302-1310. PubMed ID: 33581321
[TBL] [Abstract][Full Text] [Related]
2. Identification of Novel Cdc7 Kinase Inhibitors as Anti-Cancer Agents that Target the Interaction with Dbf4 by the Fragment Complementation and Drug Repositioning Approach.
Cheng AN; Lo YK; Lin YS; Tang TK; Hsu CH; Hsu JT; Lee AY
EBioMedicine; 2018 Oct; 36():241-251. PubMed ID: 30293817
[TBL] [Abstract][Full Text] [Related]
3. Identification of an old antibiotic clofoctol as a novel activator of unfolded protein response pathways and an inhibitor of prostate cancer.
Wang M; Shim JS; Li RJ; Dang Y; He Q; Das M; Liu JO
Br J Pharmacol; 2014 Oct; 171(19):4478-89. PubMed ID: 24903412
[TBL] [Abstract][Full Text] [Related]
4. [Recent updates on the antibacterial clofoctol.].
Sacco O; Salvati P; Rossi GA
Recenti Prog Med; 2023 Jan; 114(1):1-5. PubMed ID: 36621918
[TBL] [Abstract][Full Text] [Related]
5. The antibiotic clofoctol suppresses glioma stem cell proliferation by activating KLF13.
Hu Y; Zhang M; Tian N; Li D; Wu F; Hu P; Wang Z; Wang L; Hao W; Kang J; Yin B; Zheng Z; Jiang T; Yuan J; Qiang B; Han W; Peng X
J Clin Invest; 2019 May; 129(8):3072-3085. PubMed ID: 31112526
[TBL] [Abstract][Full Text] [Related]
6. Clofoctol inhibits SARS-CoV-2 replication and reduces lung pathology in mice.
Belouzard S; Machelart A; Sencio V; Vausselin T; Hoffmann E; Deboosere N; Rouillé Y; Desmarets L; Séron K; Danneels A; Robil C; Belloy L; Moreau C; Piveteau C; Biela A; Vandeputte A; Heumel S; Deruyter L; Dumont J; Leroux F; Engelmann I; Alidjinou EK; Hober D; Brodin P; Beghyn T; Trottein F; Deprez B; Dubuisson J
PLoS Pathog; 2022 May; 18(5):e1010498. PubMed ID: 35587469
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of human CDC7 kinase in complex with its activator DBF4.
Hughes S; Elustondo F; Di Fonzo A; Leroux FG; Wong AC; Snijders AP; Matthews SJ; Cherepanov P
Nat Struct Mol Biol; 2012 Nov; 19(11):1101-7. PubMed ID: 23064647
[TBL] [Abstract][Full Text] [Related]
8. Dbf4 and Cdc7 proteins promote DNA replication through interactions with distinct Mcm2-7 protein subunits.
Ramer MD; Suman ES; Richter H; Stanger K; Spranger M; Bieberstein N; Duncker BP
J Biol Chem; 2013 May; 288(21):14926-35. PubMed ID: 23549044
[TBL] [Abstract][Full Text] [Related]
9. Regulation and roles of Cdc7 kinase under replication stress.
Yamada M; Masai H; Bartek J
Cell Cycle; 2014; 13(12):1859-66. PubMed ID: 24841992
[TBL] [Abstract][Full Text] [Related]
10. Novel fission yeast Cdc7-Dbf4-like kinase complex required for the initiation and progression of meiotic second division.
Nakamura T; Nakamura-Kubo M; Nakamura T; Shimoda C
Mol Cell Biol; 2002 Jan; 22(1):309-20. PubMed ID: 11739743
[TBL] [Abstract][Full Text] [Related]
11. Can we use hydroxychloroquine to treat COVID-19 now?
Chen J; Liu D; Yin L; Zhang L; Lu H
Int J Antimicrob Agents; 2021 Jan; 57(1):106173. PubMed ID: 33408016
[No Abstract] [Full Text] [Related]
12. Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach.
Molavi Z; Razi S; Mirmotalebisohi SA; Adibi A; Sameni M; Karami F; Niazi V; Niknam Z; Aliashrafi M; Taheri M; Ghafouri-Fard S; Jeibouei S; Mahdian S; Zali H; Ranjbar MM; Yazdani M
Biomed Pharmacother; 2021 Jun; 138():111544. PubMed ID: 34311539
[TBL] [Abstract][Full Text] [Related]
13. DDK dependent regulation of TOP2A at centromeres revealed by a chemical genetics approach.
Wu KZ; Wang GN; Fitzgerald J; Quachthithu H; Rainey MD; Cattaneo A; Bachi A; Santocanale C
Nucleic Acids Res; 2016 Oct; 44(18):8786-8798. PubMed ID: 27407105
[TBL] [Abstract][Full Text] [Related]
14. The Dbf4-Cdc7 kinase promotes Mcm2-7 ring opening to allow for single-stranded DNA extrusion and helicase assembly.
Bruck I; Kaplan DL
J Biol Chem; 2015 Jan; 290(2):1210-21. PubMed ID: 25471369
[TBL] [Abstract][Full Text] [Related]
15. Use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.
Goldman JD; Diaz G; Urba WJ
Int J Antimicrob Agents; 2021 Jan; 57(1):106174. PubMed ID: 33408020
[No Abstract] [Full Text] [Related]
16. Advanced statistical methods and designs for clinical trials for COVID-19.
Shan G; Wang W
Int J Antimicrob Agents; 2021 Jan; 57(1):106167. PubMed ID: 33408032
[No Abstract] [Full Text] [Related]
17. Molecular mechanism of activation of human Cdc7 kinase: bipartite interaction with Dbf4/activator of S phase kinase (ASK) activation subunit stimulates ATP binding and substrate recognition.
Kitamura R; Fukatsu R; Kakusho N; Cho YS; Taniyama C; Yamazaki S; Toh GT; Yanagi K; Arai N; Chang HJ; Masai H
J Biol Chem; 2011 Jul; 286(26):23031-43. PubMed ID: 21536671
[TBL] [Abstract][Full Text] [Related]
18. Lack of Effectiveness of Repurposed Drugs for COVID-19 Treatment.
Martinez MA
Front Immunol; 2021; 12():635371. PubMed ID: 33777024
[No Abstract] [Full Text] [Related]
19. Doxycycline as an Alternative to Azithromycin in Elderly Patients.
Malek AE; Granwehr BP
Int J Antimicrob Agents; 2021 Jan; 57(1):106168. PubMed ID: 33408018
[No Abstract] [Full Text] [Related]
20. Regulation of the expression and activity of Unr in mammalian cells.
Anderson EC; Catnaigh PÓ
Biochem Soc Trans; 2015 Dec; 43(6):1241-6. PubMed ID: 26614667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
